A detailed history of Capital Wealth Planning, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Wealth Planning, LLC holds 6,970 shares of ABBV stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,970
Previous 8,482 17.83%
Holding current value
$1.23 Million
Previous $1.45 Million 5.36%
% of portfolio
0.01%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $247,726 - $301,386
-1,512 Reduced 17.83%
6,970 $1.38 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $175,222 - $204,620
-1,132 Reduced 11.77%
8,482 $1.45 Million
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $1.54 Million - $1.75 Million
9,614 New
9,614 $1.75 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $270,118 - $312,702
2,022 New
2,022 $301,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $173,263 - $220,274
-1,259 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $166,162 - $206,161
1,259 New
1,259 $204,000
Q4 2021

Feb 04, 2022

SELL
$107.43 - $135.93 $245,692 - $310,871
-2,287 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $88,099 - $100,005
-828 Reduced 26.58%
2,287 $247,000
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $34,088 - $37,976
-324 Reduced 9.42%
3,115 $351,000
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $63,119 - $69,486
-617 Reduced 15.21%
3,439 $372,000
Q4 2020

Jan 25, 2021

SELL
$80.49 - $108.67 $266,582 - $359,915
-3,312 Reduced 44.95%
4,056 $450,000
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $82,387 - $96,695
-959 Reduced 11.52%
7,368 $645,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $300,083 - $401,556
-4,090 Reduced 32.94%
8,327 $818,000
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $308,890 - $468,316
4,789 Added 62.78%
12,417 $946,000
Q4 2019

Feb 26, 2020

SELL
$72.13 - $90.25 $171,813 - $214,975
-2,382 Reduced 23.8%
7,628 $675,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $117,394 - $141,142
1,864 Added 22.88%
10,010 $769,000
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $535,192 - $684,101
8,146 New
8,146 $592,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Wealth Planning, LLC Portfolio

Follow Capital Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Planning, LLC with notifications on news.